BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21324034)

  • 1. A rare tumor: syringocystadenocarcinoma papilliferum.
    Aydin OE; Sahin B; Ozkan HS; Gore O
    Dermatol Surg; 2011 Feb; 37(2):271-4. PubMed ID: 21324034
    [No Abstract]   [Full Text] [Related]  

  • 2. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
    Arslan H; Diyarbakrl M; Batur S; Demirkesen C
    J Craniofac Surg; 2013 Jan; 24(1):e38-40. PubMed ID: 23348331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenocarcinoma papilliferum with locoregional metastases.
    Satter E; Grady D; Schlocker CT
    Dermatol Online J; 2014 Apr; 20(4):22335. PubMed ID: 24746298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringocystadenocarcinoma Papilliferum In Situ, a Variant of Cutaneous Adenocarcinoma In Situ: A Case Report With Literature Review.
    Chen J; Beg M; Chen S
    Am J Dermatopathol; 2016 Oct; 38(10):762-5. PubMed ID: 27533073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum.
    Arai Y; Kusakabe H; Kiyokane K
    J Dermatol; 2003 Feb; 30(2):146-50. PubMed ID: 12692383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Histological Snapshot of Hypothetical Multistep Progression From Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum.
    Parekh V; Guerrero CE; Knapp CF; Elmets CA; McKay KM
    Am J Dermatopathol; 2016 Jan; 38(1):56-62. PubMed ID: 26317389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microcystic adnexal carcinoma associated with multiple benign syringomatous proliferations: a report of two cases.
    Liang CA; Busam KJ; Nehal KS
    Dermatol Surg; 2011 Oct; 37(10):1515-8. PubMed ID: 21649791
    [No Abstract]   [Full Text] [Related]  

  • 8. Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin.
    Langner C; Ott A
    APMIS; 2009 Feb; 117(2):148-50. PubMed ID: 19239438
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-standing exophytic mass in the right infratemporal region. Syringocystadenocarcinoma papilliferum.
    Mohanty SK; Pradhan D; Diwaker P; Gami A; Hanna IT; Freedman AM; Turi GK
    Int J Dermatol; 2014 May; 53(5):539-42. PubMed ID: 24602090
    [No Abstract]   [Full Text] [Related]  

  • 10. Syringocystadenocarcinoma papilliferum: a case report.
    Park SH; Shin YM; Shin DH; Choi JS; Kim KH
    J Korean Med Sci; 2007 Aug; 22(4):762-5. PubMed ID: 17728526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringocystadenocarcinoma papilliferum in situ of the penis.
    Plant MA; Sade S; Hong C; Ghazarian DM
    Eur J Dermatol; 2012; 22(3):405-6. PubMed ID: 22510243
    [No Abstract]   [Full Text] [Related]  

  • 12. Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report.
    Woestenborghs H; Van Eyken P; Dans A
    Histopathology; 2006 Jun; 48(7):869-70. PubMed ID: 16722938
    [No Abstract]   [Full Text] [Related]  

  • 13. Basal cell carcinoma, syringocystadenoma papilliferum, trichilemmoma, and sebaceoma arising within a nevus sebaceus associated with pigmented nevi.
    Wang Y; Bu WB; Chen H; Zhang ML; Zeng XS; Zhao L; Fang F
    Dermatol Surg; 2011 Dec; 37(12):1806-10. PubMed ID: 22093024
    [No Abstract]   [Full Text] [Related]  

  • 14. Scrotal syringocystadenoma papilliferum: case report.
    Abdulla AN; Covert AA; Grantmyre JE
    Can J Urol; 2009 Jun; 16(3):4684-6. PubMed ID: 19497181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
    Peterson J; Tefft K; Blackmon J; Rajpara A; Fraga G
    Dermatol Online J; 2013 Sep; 19(9):19620. PubMed ID: 24050294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringocystadenoma papilliferum: Unusual location.
    Elfatoiki F; Khadir K; Ouakadi A; Azzouzi S; Bahechar N; Benchikhi H
    Dermatol Online J; 2011 Jun; 17(6):7. PubMed ID: 21696687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringocystadenocarcinoma papilliferum.
    Sroa N; Sroa N; Zirwas M
    Dermatol Surg; 2010 Feb; 36(2):261-3. PubMed ID: 20002633
    [No Abstract]   [Full Text] [Related]  

  • 18. Syringocystadenoma papilliferum: an unusual cutaneous lesion in a pediatric patient.
    Townsend TC; Bowen AR; Nobuhara KK
    J Pediatr; 2004 Jul; 145(1):131-3. PubMed ID: 15238924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature.
    Leeborg N; Thompson M; Rossmiller S; Gross N; White C; Gatter K
    Arch Pathol Lab Med; 2010 Aug; 134(8):1205-9. PubMed ID: 20670144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringocystadenocarcinoma papilliferum in situ: report of a case with late recurrence.
    Castillo L; Moreno A; Tardío JC
    Am J Dermatopathol; 2014 Apr; 36(4):348-52. PubMed ID: 24394301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.